phenylarsonous acid has been researched along with Osteosarcoma in 1 studies
*Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hogg, PJ; Lu, H; Noy, JM; Stenzel, M; Yang, JL | 1 |
1 other study(ies) available for phenylarsonous acid and Osteosarcoma
| Article | Year |
|---|---|
Direct Polymerization of the Arsenic Drug PENAO to Obtain Nanoparticles with High Thiol-Reactivity and Anti-Cancer Efficiency.
Topics: Antineoplastic Agents; Arsenicals; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Humans; Mitochondria; Nanoparticles; Osteosarcoma; Polymerization; Polymers; Sulfhydryl Compounds | 2018 |